Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | NU-0129 |
Synonyms | |
Therapy Description |
NU-0129 comprises sphericle nucleic acid gold nanoparticles made up of siRNAs that specifically target BCL2L12, thereby blocking translation of BCL2L12 and subsequently, resulting in apoptotic activity (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NU-0129 | SNA NU-0129 | NU-0129 comprises sphericle nucleic acid gold nanoparticles made up of siRNAs that specifically target BCL2L12, thereby blocking translation of BCL2L12 and subsequently, resulting in apoptotic activity (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|